icotinib
Ligand Summary
Icotinib is a new epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that developed and used in China for the treatment of patients with non-small cell lung cancer (NSCLC).
UNII: 9G6U5L461Q
PubChem: 22024915
Guide to Pharmacology: 7641
ChEMBL: CHEMBL2087361
DrugCentral: 5209
LyCHI: 5P9F71NB22TL
Target Activities
6 Activities
Items per page:
10
1 – 6 of 6
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
Kd | ||||||
IC50 | INHIBITOR | |||||
Kd | ||||||